Chemokines induce migrational responses in human breast carcinoma cell lines

International Journal of Cancer

Volumn 71, Issue 2, 1997, Pages 257-266

  Youngs, Sara J ^a   Ali, Selman A ^b   Taub, Dennis D ^c   Rees, Robert C ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ACTIN POLYMERIZATION; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ACTINS; BREAST NEOPLASMS; CELL MOVEMENT; CHEMOKINES; CHOLERA TOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; MICROSCOPY, FLUORESCENCE; RANTES; TIME FACTORS; TUMOR CELLS, CULTURED; VIRULENCE FACTORS, BORDETELLA;

EID: 0030967081     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970410)71:2<257::AID-IJC22>3.0.CO;2-D     Document Type: Article

References (23)

1. BAGGIOLINI, M., DEWALD, D. and MOSER, B., Interleukin 8 and related chemotactic cytokines CXC and CC chemokines. Adv. Immunol., 53, 97-179 (1994).
2. ENGEL, L.W., YOUNG, N.A., TRALKA, T.S., LIPPMAN, M.E., O'BRIEN, S.J. and JOYCE, M.J., Establishment and characterisation of three new continous cell lines derived from human breast carcinomas. Cancer Res., 38, 3352-3364 (1978).
3. HELMAN, L.J. and THIELE, C.J., New insights into the causes of cancer. Pediatr. Clin. North Amer., 38, 201-221 (1991).
4. HIROSE, K., HAKOZAKI, M., NYUNOYA, Y., KOBAVASHI, Y., MATSUSHITA, K., TAKENOUCHI, T., MIKATA, A., MUKAIDA, N. and MATSUSHIMA, K., Chemokine gene transfection into tumour cells reduced tumourgenicity in nude mice in association with neutrophilic infiltration. Brit. J Cancer, 72, 708-714 (1995).
5. KELNER, G.S., KENNEDY, J., BACON, K.B., KLEYENSTEUBER, S., LARGAESPADA, D.A., JENKINS, N.E., COPELAND, N.G., BAZAN, J.F., MOORE, K.W., SCHALL, T.J. and ZLOTNIK, A., Lymphotactin: a cytokine that represents a new class of chemokine. Science, 266, 1395-1399 (1994).
6. KEYDAR, I., CHEN, L., KARBY, S., WEISS, F.R., DELAREA, J., RADU, M., CHAITCIK, S. and BRENNER, H.J., Establishment and characterization of a cell line of human breast carcinoma origin. Cancer Res., 38, 659-670 (1978).
7. LANING, J., KAWASAKI, H., TANAKA, E., LUO, Y. and DORF, M.E., Inhibition of in vivo tumor growth by the beta chemokine TCA3. J. Immunol., 154, 4625-4635 (1994).
8. LESTER, B.R. and MCCARTHY, J.B., Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis. Cancer Metastasis Rev., 11, 31-44 (1992).
9. NEGUS, R.P.M., ALLAVENA, P., SOZZANI, S., MANTOVANI, A. and BALKWILL, F.R., The detection and localisation of monocyte chemoattractant protein 1 (MCP-1) in human ovarian cancer. J. clin. Invest., 95, 2391-2396 (1995).
10. OPDENAKKER, G. and VAN DAMME, J., Chemotactic factors, passive invasion and metastasis of cancer cells. Immunol. Today, 13, 463-464 (1992a).
11. OPDENAKKER, G. and VAN DAMME, J., Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer, Cytokine, 4, 251-258 (1992b).
12. POKORNA, E., JORDAN, P.W., O'NEILL, C.H., ZICHA, D., GILBERT, C.S. and VESELY, P., Actin cytoskeleton and motility in rat sarcoma cell populations with different metastatic potential. Cell Motility Cytoskeleton, 28, 25-33 (1994).
13. ROLLINS, B.J. and SUNDAY, M.E., Suppression of tumor formation in vivo by expression, of the JE gene in malignant cells. Mol. Cell Biol., 11, 3125-3131 (1991).
14. SOMMERS, C.L. BYERS, S.W., THOMPSON, E.W., TORRI, J.A. and GELMANN, E.P., Differentiation state and invasiveness of human breast cell lines. Breast Cancer Res. Treat., 31, 325-335 (1994).
15. SOULE, H.D., VAZQUEZ, J., LONG, A., ALBERT, S. and BRENNAN, M., A human cell line from a pleural effusion derived from a breast carcinoma. J. nat. Cancer Inst., 51, 1409-1416 (1973).
16. SOZZANI, S., LOCATI, D., ZHOU, D., RIEPPI, M., LUINI, W., LAMORSE, G., BIANCHI, G., POLENTARUTTI, N., ALLAVENE, P. and MANTOVANI, A., Receptor, signal transduction and spectrum of action of monocytic chemotactic protein 1 and related chemokines. J. Leukocyte Biol., 57, 788-794 (1995).
17. STRIETER, R.M., POLVERINI, P.J., ARENBERG, D.A. and KUNKEL, S.L., The role of CXC chemokines as regulators of angiogenesis. Shock, 4, 155-160 (1995).
18. TAUB, D.D., SAVERS, T.J., CARTER, C.R.D. and ORTALDO, O.R., Alpha and beta chemokines induce NK cell migration and enhanced NK mediated cytolosis. J. Immunol., 155, 3877-3888 (1995).
19. VERSCHUEREN, H., VAN DER TAELEN, I., DEWIT, J., DE BRAEKELEER, J. and DE BAETSELIER, P., Metastatic competence of BW5147 T lymphoma cell lines is correlated with in vitro metastasis. J. Leukocyte Biol., 55, 552-556 (1994).
20. WANG, J.M., SHERRY, B., FIVASH, M.J., KELVIN, D.J. and OPPENHEIM, J.J., Human recombinant macrophage inflammatory protein-1α and -1β and monocyte chemotactic and activating factor utilize common and unique receptors on human monocytes. J. Immunol., 150, 3022-3029 (1993).
21. WANG, M.J., TARABOLETTI, G., MATSUSHIMA, K., VAN DAMME, J. and MANTOVANI, A., Induction of haptotactic migration of melanoma cells by neutrophil activating protein/Interleukin 8. Biochem. biophys. Res. Comm., 169, 165-170 (1990).
22. YABKOWITZ, R., MANSFIELD, P.J., DIXIT, V.M. and SUCHARD, S.J., Motility of human carcinoma cells in response to thrombospondin: relationship to metastatic potential and thrombospondin structure domains. Cancer Res., 53, 378-387 (1993).
23. YOSHIDA, T., IMAI, T., KAKIZAKI, M., HISHIMURA, M. and YOSHIE, O., Molecular cloning of a novel C or γ type chemokine SCM-1. FEBS Lett., 360, 155-159 (1995).